Tau Protein News and Research

RSS

Tau proteins are microtubule-associated proteins found in neurons in the brain.

Light therapy may dramatically reduce neurodegeneration in Alzheimer’s disease

Researchers at MIT have found that light therapy can enhance synaptic function and protect against cell death in Alzheimer’s disease.

9 May 2019

New two-tier method can enable early-stage detection of Alzheimer’s

Using current techniques, Alzheimer's disease, the most frequent cause of dementia, can only be detected once the typical plaques have formed in the brain.

3 May 2019

Measuring biomarkers in blood may help pinpoint newborns with HIE

Measuring a number of biomarkers over time that are produced as the body responds to inflammation and injury may help to pinpoint newborns who are more vulnerable to suffering lasting brain injury due to disrupted oxygen delivery and blood flow, according to research presented during the Pediatric Academic Societies 2019 Annual Meeting.

27 Apr 2019

Researchers observe correlation between abnormal proteins and aggressive behavior in dementia

Researchers at Lund University in Sweden have together with American colleagues studied deceased patients who were diagnosed with Alzheimer's disease or frontotemporal dementia.

12 Apr 2019

Researchers use experimental PET to detect abnormal tau in brains of living former NFL players

Using an experimental positron emission tomography scan, researchers have found elevated amounts of abnormal tau protein in brain regions players with cognitive, mood and behavior symptoms.

11 Apr 2019

Scientists develop technique to clear abnormal tau protein from human neurons

Harnessing a probe used to image the brain in diagnosing Alzheimer's disease and related forms of dementia, scientists at Dana-Farber Cancer Institute and Massachusetts General Hospital have successfully cleared patient-derived brain cells of an abnormal protein associated with dementia and other neurogenerative disorders.

10 Apr 2019

Cerveau announces research collaboration agreement with Eisai for novel tau imaging agent

Cerveau Technologies, Inc. today announced a research collaboration agreement with Eisai Inc., which will enable Eisai to use Cerveau's [F-18]MK-6240, an investigational imaging agent, in Positron Emission Tomography scans to assess the status and progression of neurofibrillary tangles in the brain.

25 Mar 2019

Hidden differences between pathology of CTE and Alzheimer's disease discovered

An international team of scientists at Indiana University School of Medicine, University of Kansas and the U.K. Medical Research Council have dismantled the belief that Alzheimer's disease and Chronic Traumatic Encephalopathy have identical pathology.

22 Mar 2019

Research team identifies potential target protein aggregates for treating Alzheimer's disease

The aggregation of alpha-synuclein proteins in Parkinson's disease and tau proteins in Alzheimer's disease is intimately linked to the progression of these neurodegenerative diseases. These aggregates propagate from one neuronal cell to another, attaching themselves to the cells.

8 Mar 2019

Sleep apnea may be linked to higher tau accumulations in the brain, study finds

People who stop breathing during sleep may have higher accumulations of the toxic protein tau, a biological hallmark of Alzheimer's disease, in part of the brain that manages memory, navigation and perception of time.

5 Mar 2019

Sleep apnea linked to Alzheimer’s disease

A new study has revealed that people with obstructive sleep apnoea or those who snore at night are more at risk of dementias and Alzheimer’s disease.

4 Mar 2019

Sleep apnea could be linked to accumulation of Alzheimer’s disease biomarker

People with sleep apnea may be more likely to have higher accumulations of an Alzheimer’s disease biomarker called tau, according to a study presented at the American Academy of Neurology.

4 Mar 2019

Sleep apnea may be related to higher accumulation of Alzheimer's biomarker in the brain

People who are witnessed by a bed partner to have stopped breathing during sleep may have higher accumulations of an Alzheimer's disease biomarker called tau in an area of the brain that helps with memory, according to a preliminary study released today that will be presented at the American Academy of Neurology's 71st Annual Meeting in Philadelphia, May 4 to 10, 2019.

4 Mar 2019

USC researchers use AI to identify blood-based markers of Alzheimer's disease

Nearly 50 million people worldwide have Alzheimer's disease or another form of dementia. While age is the greatest risk factor for developing the disease, researchers believe most Alzheimer's cases occur as a result of complex interactions among genes and other factors. But those factors and the role they play are not known--yet.

29 Jan 2019

Low doses of anti-HIV drug appear to reduce tau protein in neurons of Alzheimer’s patients

The accumulation of amyloid beta plaques and tangles of a protein called tau in the brain are hallmarks of Alzheimer's disease.

27 Jan 2019

Researchers discover new changes occurring in the brain in early Alzheimer's disease

Researchers at the University of Eastern Finland have discovered new changes occurring in the human brain in the early stages of Alzheimer's disease.

21 Dec 2018

Ultrasensitive test detects corrupted protein associated with Alzheimer's and CTE

An ultrasensitive test has been developed that detects a corrupted protein associated with Alzheimer's disease and chronic traumatic encephalopathy, a condition found in athletes, military veterans, and others with a history of repetitive brain trauma.

20 Dec 2018

Tau protein reduces neural activity in Alzheimer's mouse models

A study from Massachusetts General Hospital investigators sheds new light on how the hallmarks of Alzheimer's disease - amyloid-beta (A-beta) plaques and neurofibrillary tangles containing the protein tau - produce their damaging effects in the brain.

19 Dec 2018

Study uncovers novel details about vulnerability of one brain cell to Alzheimer's

Better tactics for detecting, preventing and treating Alzheimer's disease depend on a clearer understanding of cellular-level changes in the minds of patients, and a new study has uncovered novel details about the vulnerability of one type of brain cell.

18 Dec 2018

Research opens door to development of drug or vaccine for late-onset Alzheimer's

UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer's disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.

17 Dec 2018

Tau Protein News and Research

Further Reading

Light therapy may dramatically reduce neurodegeneration in Alzheimer’s disease

New two-tier method can enable early-stage detection of Alzheimer’s

Measuring biomarkers in blood may help pinpoint newborns with HIE

Researchers observe correlation between abnormal proteins and aggressive behavior in dementia

Researchers use experimental PET to detect abnormal tau in brains of living former NFL players

Scientists develop technique to clear abnormal tau protein from human neurons

Cerveau announces research collaboration agreement with Eisai for novel tau imaging agent

Hidden differences between pathology of CTE and Alzheimer's disease discovered

Research team identifies potential target protein aggregates for treating Alzheimer's disease

Sleep apnea may be linked to higher tau accumulations in the brain, study finds

Sleep apnea linked to Alzheimer’s disease

Sleep apnea could be linked to accumulation of Alzheimer’s disease biomarker

Sleep apnea may be related to higher accumulation of Alzheimer's biomarker in the brain

USC researchers use AI to identify blood-based markers of Alzheimer's disease

Low doses of anti-HIV drug appear to reduce tau protein in neurons of Alzheimer’s patients

Researchers discover new changes occurring in the brain in early Alzheimer's disease

Ultrasensitive test detects corrupted protein associated with Alzheimer's and CTE

Tau protein reduces neural activity in Alzheimer's mouse models

Study uncovers novel details about vulnerability of one brain cell to Alzheimer's

Research opens door to development of drug or vaccine for late-onset Alzheimer's

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest Life Science News